Biopsy Devices Market Segmentation:
Product Type Segment Analysis
The needle-based biopsy guns segment is expected to garner the highest share of 43.8 % in the biopsy devices market by the end of 2035. The dominance of the segment is subject to the capability of these devices to offer minimally invasive procedures with higher accuracy, thereby resulting in higher patient preference and adoption. Besides, as there is a fast-rising prevalence of cancer cases across the world, the demand for needle-based biopsy gun also rises allowing the market to expand more.
Application Segment Analysis
The breast biopsy segment is projected to grow at a considerable rate in the biopsy devices market during the forecast period. The growth in the segment is attributable to the increasing instances of breast cancer among women across the world, which drives the demand for early diagnosis. Besides the government-backed initiatives, such as mammography programs increase biopsy procedures. Moreover, VAB and stereotactic-guided biopsies are the gold standards for breast lesions thereby augmenting segment’s growth.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Application |
|
|
End user |
|
